Literature DB >> 27859502

The origin of fibrogenic myofibroblasts in fibrotic liver.

Tatiana Kisseleva1.   

Abstract

Liver fibrosis results from chronic liver injury of different etiologies. It is characterized by dysregulation of physiological remodeling, activation of myofibroblasts, and formation of a fibrous scar. Myofibroblasts develop contractile functions and secrete the extracellular matrix proteins that form this fibrous scar. Myofibroblasts are not present in the normal liver but activate and proliferate in response to injury and inflammation. This review summarizes the understanding and controversies on the contribution of cell populations to the myofibroblasts in liver fibrosis. (Hepatology 2017;65:1039-1043).
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2017        PMID: 27859502      PMCID: PMC5476301          DOI: 10.1002/hep.28948

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

1.  Hepatocyte-derived Snail1 propagates liver fibrosis progression.

Authors:  R Grant Rowe; Yongshun Lin; Ryoko Shimizu-Hirota; Shinichiro Hanada; Eric G Neilson; Joel K Greenson; Stephen J Weiss
Journal:  Mol Cell Biol       Date:  2011-04-11       Impact factor: 4.272

Review 2.  Myofibroblasts.

Authors:  Boris Hinz
Journal:  Exp Eye Res       Date:  2015-07-17       Impact factor: 3.467

3.  Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver.

Authors:  Kinji Asahina; Bin Zhou; William T Pu; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2011-02-03       Impact factor: 17.425

4.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.

Authors:  David Cassiman; Louis Libbrecht; Valeer Desmet; Carl Denef; Tania Roskams
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

5.  A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.

Authors:  Scott T Magness; Ramón Bataller; Liu Yang; David A Brenner
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

6.  Phenotypic change in portal fibroblasts in biliary fibrosis.

Authors:  L Tang; Y Tanaka; F Marumo; C Sato
Journal:  Liver       Date:  1994-04

7.  Myofibroblastic Conversion and Regeneration of Mesothelial Cells in Peritoneal and Liver Fibrosis.

Authors:  Ingrid Lua; Yuchang Li; Lamioko S Pappoe; Kinji Asahina
Journal:  Am J Pathol       Date:  2015-12       Impact factor: 4.307

8.  A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice.

Authors:  Juan E Puche; Youngmin A Lee; Jingjing Jiao; Costica Aloman; Maria I Fiel; Ursula Muñoz; Thomas Kraus; Tingfang Lee; Hal F Yee; Scott L Friedman
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

9.  Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers.

Authors:  Ingrid Lua; Yuchang Li; Jessica A Zagory; Kasper S Wang; Samuel W French; Jean Sévigny; Kinji Asahina
Journal:  J Hepatol       Date:  2016-01-19       Impact factor: 25.083

10.  Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.

Authors:  Christine C Hsu; Juliane S Troeger; Ingmar Mederacke; Peter Huebener; Xueru Mu; Dianne H Dapito; Jean-Philippe Pradere; Robert F Schwabe
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  56 in total

1.  Myofibroblast Markers and Microscopy Detection Methods in Cell Culture and Histology.

Authors:  Fereshteh S Younesi; Dong Ok Son; Joao Firmino; Boris Hinz
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Linking Race, Cancer Outcomes, and Tissue Repair.

Authors:  Jung S Byun; Samson Park; Ambar Caban; Alana Jones; Kevin Gardner
Journal:  Am J Pathol       Date:  2017-11-11       Impact factor: 4.307

3.  Molecular Genetic and Immune Functional Responses Distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate Cells.

Authors:  Raghavan Chinnadurai; Jenna Sands; Devi Rajan; Xiao Liu; Dalia Arafat; Rahul Das; Frank A Anania; Greg Gibson; Tatiana Kisseleva; Jacques Galipeau
Journal:  Stem Cells       Date:  2019-05-09       Impact factor: 6.277

4.  Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells.

Authors:  Minkyung Bae; Mi-Bo Kim; Hyunju Kang; Young-Ki Park; Ji-Young Lee
Journal:  Lipids       Date:  2019-05-29       Impact factor: 1.880

5.  Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.

Authors:  Chen Qu; Dandan Zheng; Sai Li; Yingjun Liu; Anna Lidofsky; Jacinta A Holmes; Jianning Chen; Lu He; Lan Wei; Yadi Liao; Hui Yuan; Qimeng Jin; Zelong Lin; Qiaoting Hu; Yuchuan Jiang; Mengxian Tu; Xijun Chen; Weiming Li; Wenyu Lin; Bryan C Fuchs; Raymond T Chung; Jian Hong
Journal:  Hepatology       Date:  2018-05-21       Impact factor: 17.425

6.  Praziquantel ameliorates CCl4 -induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells.

Authors:  Jinfeng Liu; Delong Kong; Jingfan Qiu; Yanci Xie; Zhongkui Lu; Chunlei Zhou; Xinjian Liu; Rong Zhang; Yong Wang
Journal:  Br J Pharmacol       Date:  2019-12-29       Impact factor: 8.739

7.  Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis.

Authors:  Elena M Kaftanovskaya; Hooi Hooi Ng; Mariluz Soula; Bryan Rivas; Courtney Myhr; Brian A Ho; Briana A Cervantes; Thomas D Shupe; Mahesh Devarasetty; Xin Hu; Xin Xu; Samarjit Patnaik; Kenneth J Wilson; Elena Barnaeva; Marc Ferrer; Noel T Southall; Juan J Marugan; Colin E Bishop; Irina U Agoulnik; Alexander I Agoulnik
Journal:  FASEB J       Date:  2019-08-16       Impact factor: 5.191

8.  Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts via activation of the Hedgehog signaling pathway.

Authors:  Xiao-Rong Pan; Ying-Ying Jing; Wen-Ting Liu; Zhi-Peng Han; Rong Li; Yang Yang; Jing-Ni Zhu; Xiao-Yong Li; Pei-Pei Li; Li-Xin Wei
Journal:  Cell Cycle       Date:  2017-05-31       Impact factor: 4.534

9.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

10.  Hydrogen selenide, a vital metabolite of sodium selenite, uncouples the sulfilimine bond and promotes the reversal of liver fibrosis.

Authors:  Dongrui Luan; Zengteng Zhao; Dandan Xia; Qiuling Zheng; Xiaonan Gao; Kehua Xu; Bo Tang
Journal:  Sci China Life Sci       Date:  2020-09-01       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.